# A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.

> **NCT00468975** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 42 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** PF-610,355
- **DRUG:** Salmeterol

## Key facts

- **NCT ID:** NCT00468975
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 42 (—)
- **Last updated:** 2010-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00468975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00468975, "A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00468975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*